EXTARO 300: payments to doctors
Payments that named EXTARO 300 as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $330K
- Providers
- 328
- Transactions
- 620
- Average per transaction
- $532
The per-transaction average — $532 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 328 providers the average total is $1,006, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Carl Zeiss Meditec, Inc. | $162,997 | 49.4% |
| Carl Zeiss Meditec USA, Inc. | $122,896 | 37.2% |
| Carl Zeiss Meditec AG | $44,102 | 13.4% |